Literature DB >> 30502750

A clinical prescription for heart health in midlife women.

Chrisandra Shufelt1, Erika Dutra2, Tina Torbati2, Tina Ramineni2.   

Abstract

Cardiovascular disease is the leading cause of death in women throughout the United States and Europe. Despite efforts to raise awareness, the sex-specific risk factors are still poorly recognized in both regions, and many women do not identify cardiovascular disease as a primary threat. During midlife, the incidence of cardiovascular disease increases dramatically, and this unique time gives an opportunity to identify both traditional cardiovascular risk factors as well as emerging risk factors unique to women. This review will focus on the current guidelines for cardiovascular risk assessment in Europe and the United States, traditional and emerging cardiovascular risk factors, and preventive lifestyle recommendations for midlife women.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Menopause; Midlife; Prevention; Risk assessment; Sex-based differences

Mesh:

Year:  2018        PMID: 30502750      PMCID: PMC6290356          DOI: 10.1016/j.maturitas.2018.11.004

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  117 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

Review 2.  Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis.

Authors:  Holger Cramer; Romy Lauche; Heidemarie Haller; Nico Steckhan; Andreas Michalsen; Gustav Dobos
Journal:  Int J Cardiol       Date:  2014-02-25       Impact factor: 4.164

Review 3.  Physical activity and health during the menopausal transition.

Authors:  Barbara Sternfeld; Sheila Dugan
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

4.  Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.

Authors:  D E Bush; R C Ziegelstein; M Tayback; D Richter; S Stevens; H Zahalsky; J A Fauerbach
Journal:  Am J Cardiol       Date:  2001-08-15       Impact factor: 2.778

5.  15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

Authors:  Maurizio Fava; A John Rush; Michael E Thase; Anita Clayton; Stephen M Stahl; James F Pradko; J Andrew Johnston
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

6.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 7.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.

Authors:  N E Avis; D Brambilla; S M McKinlay; K Vass
Journal:  Ann Epidemiol       Date:  1994-05       Impact factor: 3.797

9.  Weight gain and smoking: perceptions and experiences of obese quitline participants.

Authors:  Terry Bush; Clarissa Hsu; Michele D Levine; Brooke Magnusson; Lyndsay Miles
Journal:  BMC Public Health       Date:  2014-11-27       Impact factor: 3.295

10.  Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study.

Authors:  A C de Kat; V Dam; N C Onland-Moret; M J C Eijkemans; F J M Broekmans; Y T van der Schouw
Journal:  BMC Med       Date:  2017-01-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.